What do analysts expect the price target to be for RLI CORP (RLI)?
12 analysts have analysed RLI and the average price target is 60.95 USD. This implies a price decrease of -0.45% is expected in the next year compared to the current price of 61.22.
NYSE:RLI • US7496071074
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RLI CORP (RLI).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-23 | Citizens | Reiterate | Market Perform -> Market Perform |
| 2026-01-23 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-23 | Jefferies | Upgrade | Underperform -> Hold |
| 2026-01-15 | Wells Fargo | Initiate | Equal-Weight |
| 2026-01-06 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-10-03 | Truist Securities | Initiate | Hold |
| 2025-04-24 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-04-24 | Compass Point | Downgrade | Buy -> Neutral |
| 2025-04-09 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2025-01-27 | Compass Point | Maintains | Buy -> Buy |
| 2025-01-27 | Jefferies | Downgrade | Buy -> Underperform |
| 2025-01-24 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-01-23 | JMP Securities | Reiterate | Market Perform -> Market Perform |
| 2025-01-10 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2024-10-25 | Compass Point | Maintains | Buy -> Buy |
| 2024-10-23 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-10-16 | Oppenheimer | Initiate | Perform |
| 2024-10-09 | Wolfe Research | Initiate | Outperform |
| 2024-10-09 | Jefferies | Maintains | Buy -> Buy |
| 2024-10-08 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-07-29 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2024-07-24 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-07-24 | Compass Point | Maintains | Buy -> Buy |
| 2024-07-23 | JMP Securities | Reiterate | Market Perform |
| 2024-06-21 | Keefe, Bruyette & Woods | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.512B -10.95% | 1.77B 17.09% | 1.882B 6.33% | 1.7B -9.69% | 1.76B 3.53% | 1.914B 8.75% | |
| EBITDA YoY % growth | 383.501M -47.24% | 446.415M 16.41% | 523.392M 17.24% | N/A | N/A | N/A | |
| EBIT YoY % growth | 374.956M -47.84% | 438.751M 17.01% | 515.263M 17.44% | 251.84M -51.12% | 252.98M 0.45% | 268.66M 6.20% | |
| Operating Margin | 24.80% | 24.78% | 27.37% | 14.81% | 14.37% | 14.04% | |
| EPS YoY % growth | 2.47 -0.20% | 2.87 16.19% | 3.53 23.00% | 2.87 -18.70% | 2.89 0.70% | 3.03 4.82% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.83 -9.35% | 0.74 -12.50% | 0.58 -29.95% | 0.80 -15.10% | 0.87 4.81% | 0.79 7.01% | 0.58 0.49% | 0.82 2.73% | 0.90 2.60% | 0.74 -6.13% | 0.59 0.61% |
| Revenue Q2Q % growth | 414.41M 4.36% | 463.46M 1.40% | 432.37M 6.15% | 422.54M 17.16% | 441.09M 6.44% | 494.54M 6.71% | 456.45M 5.57% | 436.02M 3.19% | 485.66M 10.10% | 489.93M -0.93% | 494.27M 8.29% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 79.491M 3.35% | 60.643M -60.98% | 51.144M -67.44% | 70.369M -44.10% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
12 analysts have analysed RLI and the average price target is 60.95 USD. This implies a price decrease of -0.45% is expected in the next year compared to the current price of 61.22.
RLI CORP (RLI) will report earnings on 2026-04-21, after the market close.
The consensus EPS estimate for the next earnings of RLI CORP (RLI) is 0.83 USD and the consensus revenue estimate is 414.41M USD.
The consensus rating for RLI CORP (RLI) is 68.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.